Ipilimumab vs Memantine
Ipilimumab vs Memantine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Memantine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Memantine: Non-competitive NMDA receptor antagonist.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Memantine — 60-80 hours.
Chemical Properties
Molecular Formula: Memantine — C12H21N.
Molecular Weight: Memantine — 179.3080 g/mol.
Type: Ipilimumab — Antibody; Memantine — Small molecule.